Selecting the right therapy using molecular imaging
Up to ~70% of cancer patients will not see any response from their treatment. They take on significant risk with no benefit, adverse side effects, and a large loss of time and money.
Now imagine a future where physicians use whole body diagnostics to quickly select the right therapy.
A new class of molecular imaging (PET) agents may provide a safe, non-invasive technique to image the biology of disease.